• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
Grand Rounds

Does Calorie Labeling Policy for Prepared Foods Lead to a Decrease in Consumer Purchasing?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • As of 2018, US policy requires food retailers to add calorie labels to prepared, ready-to-eat meals
  • Petimar et al. (JAMA Internal Medicine, 2022) estimated changes in calories purchased from prepared foods and potential packaged substitutes compared with control foods after calorie labeling of prepared foods in supermarkets 

METHODS:

  • Controlled interrupted time series
    • Data came from a supermarket chain
    • Locations: Maine | Massachusetts | New Hampshire | New York | Vermont
  • Exposures
    • Pre-labelling policy: April 2015 to April 2017 (2 years)
    • Post-labelling policy: May 2017 to December 2017 (7 months)
  • Study design
    • Purchased items were classified as
      • Prepared foods
      • Potential packaged substitutes for prepared foods
      • All other foods (controls)
    • Analyses of prepared and packaged foods were stratified by food category (bakery, entrées and sides, or deli meats and cheeses)
  • Primary outcome
    • Mean weekly calories per transaction purchased from prepared foods
  • Secondary outcome
    • Mean weekly calories per transaction purchased from similar packaged items (for substitution analyses)

RESULTS:

  • 173 supermarkets
  • Calorie labeling was associated with mean decreases in prepared bakery and deli items vs control foods
    • Prepared bakery items: –5.1% (95% CI, −5.8 to −4.4)
    • Prepared deli items: –11.0% (95% CI, −11.9 to −10.1)
  • No changes seen in calories per transaction with labeling for prepared entrées and sides
    • Mean change 0.3% (95% CI, −2.5 to 3.0)
  • Labeling was also associated with mean decreased calories per transaction purchased from packaged foods
    • Packaged bakery items: −3.9% (95% CI, −4.3 to −3.6)
    • Packaged entrées and sides: −1.2% (95% CI, −1.4 to −0.9)
    • Packaged deli items: −2.1% (95% CI, −2.4 to −1.7)
  • Absolute decreases in calories purchased
    • Prepared bakery: Approximately 10 calories per transaction
    • Deli items: Approximately 18 calories per transaction
  • Results similar regardless of socioeconomic status of supermarket neighborhoods

CONCLUSION:

  • Adding calorie labels to prepared foods in supermarkets was associated with small to moderate decreases in calories purchased from prepared bakery and deli items but not entrées or sides
  • The prepared items were not replaced with similar packaged items by the customer
  • The authors state

To our knowledge, this is the first study to estimate associations of calorie labeling with prepared food purchases in supermarkets

The exploratory analyses suggest that the declines in calories per transaction from prepared bakery and deli items may have been explained by customers purchasing fewer prepared items, rather than switching to lower-calorie items, a pattern also observed in restaurants

These declines may lead to population-level health benefits if they translate to similar changes in consumption

Learn More – Primary Sources:

Assessment of Calories Purchased After Calorie Labeling of Prepared Foods in a Large Supermarket Chain

Want to stay on top of key guidelines and research papers?

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

RCT Results: Does intermittent Fasting Improve Weight Loss in the Setting of Obesity?
Does the Type of Dietary Fat Affect Mortality and Heart Disease in Individuals with Type 2 Diabetes?
Is There A Link Between Midlife Dietary Pattern and Later Cognitive Decline?

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site